claim
Jason Bock, PhD, is the co-founder and CEO of CTMC and has over 20 years of experience in innovative biologics development and commercialisation.
Authors
Sources
- New cell therapy model accelerates cancer treatment development www.drugtargetreview.com via serper
Referenced by nodes (2)
- CTMC entity
- Jason Bock entity